Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed

NCT04386980 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped To be replaced by a different protocol

Conditions

Osteoarthritis, Knee
Osteo Arthritis Knee
Knee Pain Chronic

Interventions

DRUG: Resiniferatoxin
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.